Patents by Inventor Stephen Yip

Stephen Yip has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11935152
    Abstract: A system for identifying biomarkers in a digital image of a Hematoxylin and Eosin-stained slide of a target tissue includes a processor and an electronic network; and a memory having stored thereon computer-executable instructions that, when executed by the one or more processors, cause the computing system to: process segmented tile images determine a predicted biomarker presence; and transmit the predicted presence. A non-transitory computer-readable medium includes a set of computer-executable instructions that, when executed by one or more processors, cause a computer to: process segmented tile images; determine a predicted biomarker presence; and transmit the predicted presence. A computer-implemented method includes processing segmented tile images; determining a predicted biomarker presence; and transmitting the predicted presence.
    Type: Grant
    Filed: March 20, 2023
    Date of Patent: March 19, 2024
    Assignee: TEMPUS LABS, INC.
    Inventors: Stephen Yip, Irvin Ho, Lingdao Sha, Boleslaw Osinski, Aly Azeem Khan, Andrew J. Kruger, Michael Carlson, Abel Greenwald, Caleb Willis
  • Patent number: 11918374
    Abstract: A system for monitoring organ health during treatment for cancer and the like makes use of physiological imaging of the kind used for treatment monitoring and organ-specific processing to provide a comprehensive assessment of treatment side-effects.
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: March 5, 2024
    Assignees: Wisconsin Alumni Research Foundation, AIQ Global, Inc.
    Inventors: Robert Jeraj, Daniel Huff, Timothy Perk, Stephen Yip, Glenn Liu
  • Publication number: 20240055081
    Abstract: A deep learning pipeline can be configured to use medical image data to generate predictions of therapeutic responses to a new treatment in members of a cohort of interest of treatment candidates. A plurality of respective deep learning networks may be trained using respective medical image datasets having respective degrees of relevance to the cohort of interest. Learned parameters of one deep learning network may be transferred in succession to another deep learning network after training the one deep learning network with a one of the respective medical image datasets and before training the other deep learning network with another medical image dataset of the respective medical image datasets.
    Type: Application
    Filed: August 15, 2023
    Publication date: February 15, 2024
    Applicant: Janssen Research & Development, LLC
    Inventors: FNU Darshana Govind, Stephen Yip
  • Publication number: 20230230195
    Abstract: A system for identifying biomarkers in a digital image of a Hematoxylin and Eosin-stained slide of a target tissue includes a processor and an electronic network; and a memory having stored thereon computer-executable instructions that, when executed by the one or more processors, cause the computing system to: process segmented tile images determine a predicted biomarker presence; and transmit the predicted presence. A non-transitory computer-readable medium includes a set of computer-executable instructions that, when executed by one or more processors, cause a computer to: process segmented tile images; determine a predicted biomarker presence; and transmit the predicted presence. A computer-implemented method includes processing segmented tile images; determining a predicted biomarker presence; and transmitting the predicted presence.
    Type: Application
    Filed: March 20, 2023
    Publication date: July 20, 2023
    Inventors: Stephen Yip, Irvin Ho, Lingdao Sha, Boleslaw Osinski, Aly Azeem Khan, Andrew J. Kruger, Michael Carlson, Abel Greenwald, Caleb Willis
  • Patent number: 11682098
    Abstract: A generalizable and interpretable deep learning model for predicting biomarker status and biomarker metrics from histopathology slide images is provided.
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: June 20, 2023
    Assignee: TEMPUS LABS, INC.
    Inventors: Stephen Yip, Irvin Ho, Lingdao Sha, Boleslaw Osinski
  • Patent number: 11610307
    Abstract: A generalizable and interpretable deep learning model for predicting biomarker status and biomarker metrics from histopathology slide images is provided.
    Type: Grant
    Filed: March 4, 2021
    Date of Patent: March 21, 2023
    Assignee: TEMPUS LABS, INC.
    Inventors: Stephen Yip, Irvin Ho, Lingdao Sha, Boleslaw Osinski, Aly Azeem Khan, Andrew J. Kruger, Michael Carlson, Abel Greenwald, Caleb Willis
  • Publication number: 20230046564
    Abstract: The present disclosure provides methods, systems, and non-transitory computer-readable media for assessment of disease treatment or progression on a lesion-by-lesion level. The systems and methods are based on measurements of a variety of features including total number of lesions, total number and proportion of lesions regressing or progressing, changes in dimensions of a lesion over time, and uptake values of a molecular imaging agent.
    Type: Application
    Filed: July 15, 2022
    Publication date: February 16, 2023
    Inventors: Robert JERAJ, Timothy PERK, Stephen YIP, S. Sean HOUSHMANDI
  • Publication number: 20220405919
    Abstract: A generalizable and interpretable deep learning model for predicting biomarker status and biomarker metrics from histopathology slide images is provided.
    Type: Application
    Filed: March 1, 2022
    Publication date: December 22, 2022
    Inventors: Stephen Yip, Irvin Ho, Lingdao Sha, Boleslaw Osinski, Aly Azeem Khan, Andrew J. Kruger, Michael Carlson, Abel Greenwald, Caleb Willis
  • Publication number: 20220293218
    Abstract: A method for qualifying a specimen prepared on one or more hematoxylin and eosin (H&E) slides by assessing an expected yield of nucleic acids for tumor cells and providing associated unstained slides for subsequent nucleic acid analysis is provided.
    Type: Application
    Filed: May 31, 2022
    Publication date: September 15, 2022
    Inventors: Stephen Yip, Irvin Ho, Lingdao Sha, Boleslaw Osinski, Aly Azeem Khan, Andrew J. Kruger, Michael Carlson, Abel Greenwald, Caleb Willis, Andrew Westley, Ryan Jones, Brett Mahon
  • Patent number: 11348239
    Abstract: A method for determining tumor block sufficiency for generating one or more hematoxylin and eosin (H&E) slides by assessing an expected yield of nucleic acids for tumor cells and determining a number of H&E slide for satisfying a desired total nucleic yield is provided.
    Type: Grant
    Filed: December 31, 2020
    Date of Patent: May 31, 2022
    Assignee: TEMPUS LABS, INC.
    Inventors: Stephen Yip, Irvin Ho, Lingdao Sha, Boleslaw Osinski, Aly Azeem Khan, Andrew J. Kruger, Michael Carlson, Abel Greenwald, Caleb Willis, Andrew Westley, Ryan Jones, Brett Mahon
  • Patent number: 11348661
    Abstract: A method for qualifying a specimen prepared on one or more hematoxylin and eosin (H&E) slides by assessing an expected yield of nucleic acids for tumor cells and providing associated unstained slides for subsequent nucleic acid analysis is provided.
    Type: Grant
    Filed: December 31, 2020
    Date of Patent: May 31, 2022
    Assignee: TEMPUS LABS, INC.
    Inventors: Stephen Yip, Irvin Ho, Lingdao Sha, Boleslaw Osinski, Aly Azeem Khan, Andrew J. Kruger, Michael Carlson, Abel Greenwald, Caleb Willis, Andrew Westley, Ryan Jones, Brett Mahon
  • Patent number: 11348240
    Abstract: A method for predicting an expected yield of nucleic acid from tumor cells within a dissection boundary on a hematoxylin and eosin (H&E) slide is provided.
    Type: Grant
    Filed: December 31, 2020
    Date of Patent: May 31, 2022
    Assignee: TEMPUS LABS, INC.
    Inventors: Stephen Yip, Irvin Ho, Lingdao Sha, Boleslaw Osinski, Aly Azeem Khan, Andrew J. Kruger, Michael Carlson, Abel Greenwald, Caleb Willis, Andrew Westley, Ryan Jones, Brett Mahon
  • Publication number: 20220101519
    Abstract: A generalizable and interpretable deep learning model for predicting biomarker status and biomarker metrics from histopathology slide images is provided.
    Type: Application
    Filed: April 15, 2021
    Publication date: March 31, 2022
    Inventors: Stephen Yip, Irvin Ho, Lingdao Sha, Boleslaw Osinski
  • Patent number: 11263748
    Abstract: A generalizable and interpretable deep learning model for predicting biomarker status and biomarker metrics from histopathology slide images is provided.
    Type: Grant
    Filed: February 5, 2021
    Date of Patent: March 1, 2022
    Assignee: TEMPUS LABS, INC.
    Inventors: Stephen Yip, Irvin Ho, Lingdao Sha, Boleslaw Osinski, Aly Azeem Khan, Andrew J. Kruger, Michael Carlson, Abel Greenwald, Caleb Willis
  • Publication number: 20220051410
    Abstract: A platform is provided for generating 3D models of a tumor segmented from a series of 2D medical images and for identifying from these 3D models, radiomic features that may be used for diagnostic, prognostic, and treatment response assessment of the tumor. The radiomic features may be shape-based features, intensity-based features, textural features, and filter-based features. The radiomic features are compared to remove sufficiently redundant features, thereby producing a reduced set of radiomic features, which is then compared to separate genomic data and/or outcome data to identify clinically and biologically significant radiomic features for diagnostic, prognostic, and treatment response assessment, other applications.
    Type: Application
    Filed: October 29, 2021
    Publication date: February 17, 2022
    Inventor: Stephen Yip
  • Patent number: 11189029
    Abstract: A platform is provided for generating 3D models of a tumor segmented from a series of 2D medical images and for identifying from these 3D models, radiomic features that may be used for diagnostic, prognostic, and treatment response assessment of the tumor. The radiomic features may be shape-based features, intensity-based features, textural features, and filter-based features. The radiomic features are compared to remove sufficiently redundant features, thereby producing a reduced set of radiomic features, which is then compared to separate genomic data and/or outcome data to identify clinically and biologically significant radiomic features for diagnostic, prognostic, and treatment response assessment, other applications.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: November 30, 2021
    Assignee: TEMPUS LABS, INC.
    Inventor: Stephen Yip
  • Publication number: 20210345957
    Abstract: A system for monitoring organ health during treatment for cancer and the like makes use of physiological imaging of the kind used for treatment monitoring and organ-specific processing to provide a comprehensive assessment of treatment side-effects.
    Type: Application
    Filed: April 21, 2021
    Publication date: November 11, 2021
    Inventors: Robert Jeraj, Daniel Huff, Timothy Perk, Stephen Yip, Glenn Liu
  • Publication number: 20210256690
    Abstract: A generalizable and interpretable deep learning model for predicting biomarker status and biomarker metrics from histopathology slide images is provided.
    Type: Application
    Filed: February 5, 2021
    Publication date: August 19, 2021
    Inventors: Stephen Yip, Irvin Ho, Lingdao Sha, Boleslaw Osinski, Aly Azeem Khan, Andrew J. Kruger, Michael Carlson, Abel Greenwald, Caleb Willis
  • Publication number: 20210233238
    Abstract: A generalizable and interpretable deep learning model for predicting biomarker status and biomarker metrics from histopathology slide images is provided.
    Type: Application
    Filed: March 4, 2021
    Publication date: July 29, 2021
    Inventors: Stephen Yip, Irvin Ho, Lingdao Sha, Boleslaw Osinski, Aly Azeem Khan, Andrew J. Kruger, Michael Carlson, Abel Greenwald, Caleb Willis
  • Publication number: 20210166785
    Abstract: A method for qualifying a specimen prepared on one or more hematoxylin and eosin (H&E) slides by assessing an expected yield of nucleic acids for tumor cells and providing associated unstained slides for subsequent nucleic acid analysis is provided.
    Type: Application
    Filed: December 31, 2020
    Publication date: June 3, 2021
    Inventors: Stephen Yip, Irvin Ho, Lingdao Sha, Boleslaw Osinski, Aly Azeem Khan, Andrew J. Kruger, Michael Carlson, Abel Greenwald, Caleb Willis, Andrew Westley, Ryan Jones, Brett Mahon